U.S. Patent
BIO 2017
National Cancer Conference
-
Latest News
Cancer Research News
- American Cancer Society Launches Return to Screening Initiative with Support from Genentech February 25, 2021Nationwide Effort Aims to Increase Breast, Cervical, Colorectal, and Lung Cancer Screening Rates
- Don't Let the COVID-19 Pandemic Stall Your Colorectal Cancer Screening February 25, 2021American Cancer Society urges people to talk to their doctor about getting back to screening
- One-Third of Cancer Survivors Worried About Treatment and Healthcare Disruptions During the COVID-19 Pandemic February 24, 2021
- American Cancer Society Statement Regarding Senator Bob Dole's Lung Cancer Diagnosis February 19, 2021
- American Cancer Society Announces New Diversity in Cancer Research Program - Made Permanent By a $5 Million Grant from the Elizabeth and Phill Gross Family February 9, 2021The fund will create a permanent umbrella to develop initiatives to support researchers of color and increase diversity in cancer research and patient care
- American Cancer Society Launches Return to Screening Initiative with Support from Genentech February 25, 2021
- Published on Oct 13, 2016
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT discusses the use of oncolytic viruses at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. Health Care Forum “War on Cancer” (March 30th 2017-Singapore)
-
Announcements
Related Articles
Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferondependent antiviral defense - Research Article (Biomed Central)
Childhood virus RSV shows promise against adult cancer. - Science Daily
CZ BioMed licenses children’s virus turned anti-cancer agent. - San Antonio Business Journal
Category Archives: Uncategorized
Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment
Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment Well Marker Bio Co. Ltd., a biotech division of Asan Medical Center of South Korea, signs Memorandum of Understanding with CZ Biomed Corp. and Kocal … Continue reading
Posted in Uncategorized
Leave a comment